Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1222 Vaccine Safety and Effectiveness in IMID Patients and Health Professionals
NCT05133609Phase 2Unknown
- Sponsor
- Universidade Federal do Espírito Santo
- Start
- Jan 2021
- Primary completion
- Aug 2022
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ChAdOx1 nCoV-19 in coronavirus disease 2019 (COVID-19), sponsored by Universidade Federal do Espírito Santo. Status: unknown.
02
Drugs
ChAdOx1 nCoV-19
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05133609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05133609.